Navigation Links
For Tough Head Lice, Pill Tops Lotion
Date:3/10/2010

Ivermectin may offer alternative for hard-to-treat infestations, study shows,,,,,,

WEDNESDAY, March 10 (HealthDay News)-- In children with hard-to-treat head lice, the oral medication ivermectin is more effective than the standard treatment, the topical cream malathion, new research finds.

The study, published in the March 11 issue of the New England Journal of Medicine, found that 95 percent of those treated with ivermectin were lice-free after two weeks compared to 85 percent of those using malathion.

"Ivermectin may be a good alternative to malathion when topical insecticide resistance is suspected," the study authors wrote.

The researchers caution that ivermectin generally shouldn't be used as a first-line treatment, but instead suggest that it be reserved for treatment-resistant lice. Overuse of ivermectin might lead to lice developing resistance to this medication as well.

Between 6 million and 12 million American schoolchildren are infested with head lice each year, the U.S. Centers for Disease Control and Prevention reports. Worldwide, as many as 100 million people contract head lice annually, according to background information in the study.

Although most lice infestations respond well to over-the-counter remedies, some lice have become resistant to these medications. In some cases, lice have also developed a resistance to the topical prescription medication malathion.

Ivermectin, an oral anti-parasitic drug, has been used to treat other parasitic infections, such as scabies. A previous trial on ivermectin found that a dose of 200 micrograms per kilogram of body weight was only effective in killing lice in about one out of four people, according to the study.

The current study was designed to assess the efficacy of ivermectin at twice that dose -- 400 micrograms per kilogram of body weight -- and to compare it to the standard treatment for difficult-to-treat lice.

A total of 812 children were recruited for the study. Their average age was 10. The children were put into one of two treatment groups. One group received ivermectin on days one and eight at a dose equivalent to 400 micrograms per kilogram, while the other group was treated with malathion lotion on the same days. Study medications were provided by the drug manufacturers.

Each group was also given a placebo equivalent. Those in the ivermectin group were treated with a similarly-scented lotion on treatment days, and those in the malathion group were given placebo pills on treatment days.

No other lice treatments were permitted, not even combing lice eggs (nits) from the hair.

On day 15, the researchers examined the children for evidence of continued infestation. They found that ivermectin was more effective, with 95 percent of the children lice-free. In the malathion group, 85 percent of the children treated were lice-free.

The researchers found no significant differences in the frequency of adverse events related to treatment, according to the study.

"Ivermectin looks like another tool against head lice, but there are still a number of questions to be answered," said Dr. Mark Diamond, a pediatrician affiliated with Children's Hospital of Pittsburgh. "The risk of side effects isn't totally clear, and a systemic drug vs. a topical medication is clearly a change in process. Plus, I have no idea of the cost."

One advantage of ivermectin might be that it's easier to administer, he said. "Lotions and shampoos are messy, and if all other factors are equal, parents might prefer an oral medication," said Diamond.

The good news about lice, he said, is that "a head lice infection is not serious, and it doesn't lead to other harmful diseases or complications." And, he said, most children can be effectively treated with over-the-counter medications and careful combing to remove nits from their hair.

More information

Learn more about head lice from the U.S. Centers for Disease Control and Prevention.



SOURCES: Mark Diamond, M.D., pediatrician, Pittsburgh; March 11, 2010, New England Journal of Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New Gender-Neutral Flex-Friendly Certification Makes the Business Case for Flex Even in a Tough Economy.
2. Mt. Everest Summiter Gary Guller (With One Arm) To Race Across Sahara in "The World's Toughest Stage Race"
3. Current Blood Thinners Face Tough Competition
4. WellPoint/Blue Cross Liver Transplant Denial Trial Begins Today, Illustrates Need for Toughening of White House Reform Plan
5. Firmex Achieves 237% Annual Revenue Growth Despite Tough M&A Environment in 2009
6. New Website Giving Away Diabetes-Friendly Super Bowl Munchies Recipes to Tackle America's Toughest Health Problem
7. Children's Health Insurance Program Helping Families Get Through Tough Times
8. 2010: A Tough Year Ahead for Discharge Planners, but Help Is Available
9. Small Businesses In Singapore Outmarkets & Outperforms Bigger Players in Tough Economy With Online Marketing
10. In Tough Economy SEIU-UHW Members Wage Increases Far Exceed the National Average
11. After Tough 2009, Improved Accountability and Consistent Insurance Industry Standards Key in 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... The Smart Machine Age ... Oxford University predict that 47 percent of all jobs in the United States may ... and “successful.” The day of the aggressive know-it-all who steamrolls over colleagues is drawing ...
(Date:2/24/2017)... Australia (PRWEB) , ... February 24, 2017 , ... The ... AU) offers Erik Schanssema ’s true account of his paramedic experiences. Schanssema describes ... stress disorder and his attempts to overcome them. , Schanssema, initially unsure of ...
(Date:2/24/2017)... , ... February 24, 2017 , ... The International Association ... annual “Imagine Me Beyond What You See” body image mannequin art competition. Selected from ... be showcased and the winner revealed at the 31st annual iaedp Symposium, March 22 ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Senior International Elite division on February 12th. Ms. Esparza qualified into this ... elite qualifier competition held in Las Vegas, Nevada. Frida is one of approximately ...
(Date:2/23/2017)... ... February 23, 2017 , ... The 89th Academy Awards will be celebrated ... National Education Policy Center Bunkum Award. We invite you to enjoy our 11th annual ... Bunkum winner is the Center for American Progress (CAP), for its report, Lessons From ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017  Genesis Healthcare Services has ... announcement was made by Bill Monast , President ... and Nathan Feltman , executives with Home ... Services, LLC. This acquisition helps Hospice ... of technology enabled durable medical equipment (DME) solutions for ...
(Date:2/23/2017)... CITY, Calif., Feb. 23, 2017 Nevro Corp. (NYSE: ... evidence-based solutions for the treatment of chronic pain, today reported ... December 31, 2016. 2016 Accomplishment & Highlights: ... full year 2016, an increase of 228% as reported, over ... for 2016, an increase of 612% over the prior year ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Fibromyalgia ... offering. ... latest research Fibromyalgia Drugs Price Analysis and Strategies - 2016, provides ... The research answers the following questions: ... attributes? How are they positioned in the Global Fibromyalgia market? ...
Breaking Medicine Technology: